26 results
8-K
EX-3.1
CLNN
Clene Inc
10 May 23
Departure of Directors or Certain Officers
7:06pm
, voting separately as a series or separately as a class with one or more such other series, to elect directors at an annual or special meeting … or permitted to be taken by the holders of stock of the Corporation must be effected at a duly called annual or special meeting of such holders
424B3
CLNN
Clene Inc
10 Nov 21
Prospectus supplement
4:02pm
for a period of time; and
the requirement that a special meeting of shareholders may be called only by our Board, the chairman of our Board or our Chief
424B3
CLNN
Clene Inc
10 Nov 21
Prospectus supplement
4:01pm
for a period of time; and
the requirement that a special meeting of shareholders may be called only by our Board, the chairman of our Board or our Chief
424B3
xrf8cy6s 4u73
2 Aug 21
Prospectus supplement
5:03pm
8-K
EX-3.1
tonbqlwyf7sj9g
16 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B3
ye2lghpae
24 May 21
Prospectus supplement
4:38pm
8-K
EX-3.1
pgh0iaa77
19 May 21
Clene Appoints David J. Matlin as Chairman of the Board
4:14pm
424B3
m4f k2t3mf3ro43xzdpu
21 Apr 21
Prospectus supplement
6:04am
DEF 14A
4c9gml
5 Apr 21
Definitive proxy
12:00am
10-K
u5wa50gmytly
29 Mar 21
Annual report
12:00am
PRE 14A
mmny132
18 Mar 21
Preliminary proxy
4:33pm
S-1
7r1 2xxxazw
17 Feb 21
IPO registration
12:00am
8-K
EX-3.2
spclhio hkj
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
8-K
EX-3.1
asuo7mob w6
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
424B3
azga12
18 Dec 20
Prospectus supplement
2:24pm